These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18080921)

  • 21. Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation.
    Castro GR; Coelho JC; Parolin MB; Matias JE; de Freitas AC
    Ann Transplant; 2013 Feb; 18():57-62. PubMed ID: 23792502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3, and their significance in children with left-to-right shunt congenital heart disease associated with heart failure].
    Peng J; Fu J; Deng SZ; Wang RG; Liu L; Sun DM; Xia K
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):277-80. PubMed ID: 23607950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
    Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I
    Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis.
    Ottesen LH; Bendtsen F; Flyvbjerg A
    Liver; 2001 Oct; 21(5):350-6. PubMed ID: 11589772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: relation to liver dysfunction.
    Møller S; Juul A; Becker U; Henriksen JH
    J Hepatol; 2000 Mar; 32(3):441-6. PubMed ID: 10735614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-3 in patients with liver cirrhosis.
    Sídlová K; Pechová M; Kotaska K; Průsa R
    Physiol Res; 2002; 51(6):587-90. PubMed ID: 12511182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
    Campillo B; Sherman E; Richardet JP; Bories PN
    Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Facial skin lesions in male patients with liver cirrhosis: role of serum sex hormones and correlation with impaired liver function].
    Du AS; Yang J; Lu S; Zeng JZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):354-8. PubMed ID: 24025136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study.
    Bassanello M; De Palo EF; Lancerin F; Vitale A; Gatti R; Montin U; Ciarleglio FA; Senzolo M; Burra P; Brolese A; Zanus G; D'Amico DF; Cillo U
    Liver Transpl; 2004 May; 10(5):692-8. PubMed ID: 15108263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.